Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients

1. Vázquez, L.
2. Encinas, M.P.
3. Morín, L.S.
4. Vilches, P.
5. Gutiérrez, N.
6. García-Sanz, R.
7. Caballero, D.
8. Hurlé, A.
9. San Miguel, J.F.